HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of systemic mastocytosis.

Abstract
It is an exciting time in the treatment of systemic mastocytosis. Major advances in the past 2 decades have helped to define the molecular abnormalities associated with this disease and to delineate pathways involved in its pathogenesis. This has directly translated into the development of novel targeted therapies. These therapies hold great promise to patients and health care providers that a "cure" for systemic mastocytosis may someday be obtainable.
AuthorsTodd M Wilson, Dean D Metcalfe, Jamie Robyn
JournalImmunology and allergy clinics of North America (Immunol Allergy Clin North Am) Vol. 26 Issue 3 Pg. 549-73 (Aug 2006) ISSN: 0889-8561 [Print] United States
PMID16931293 (Publication Type: Journal Article, Research Support, N.I.H., Intramural, Review)
Chemical References
  • Antineoplastic Agents
  • Inflammation Mediators
Topics
  • Antineoplastic Agents (chemistry, therapeutic use)
  • Counseling
  • Humans
  • Inflammation Mediators (immunology)
  • Mastocytosis, Systemic (therapy)
  • Patient Education as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: